SCHEMBL21708005

SCHEMBL21708005

Cc1ccc2nc(-c3ccccc3[N+](=O)[O-])cn2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 13/20 0.52
RAB9A P51151 13/20 0.52
SMN1; SMN2 Q16637 9/20 0.52
ALDH1A1 P00352 7/20 0.52
KMT2A Q03164 5/20 0.52
KDM4E B2RXH2 3/20 0.52
PKM P14618 3/20 0.52
TP53 P04637 2/20 0.52
HPGD P15428 2/20 0.52
TSHR P16473 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CDK5 Q00535 1/20 0.52
CDK5R1 Q15078 1/20 0.52
POLB P06746 3/20 0.52
GAA P10253 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
CASP3 P42574 2/20 0.52
SENP7 Q9BQF6 2/20 0.52
SENP6 Q9GZR1 2/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220899 0.83 CASP3 (0.61) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2129269 0.80 RAB9A (0.56) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2130765 0.79 RAB9A (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL1691257 0.76 RAB9A (0.73) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL1692241 0.75 RAB9A (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL21708020 0.75 NPC1 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL18807108 0.75 RAB9A (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL1984138 0.74 RAB9A (0.84) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2088912 0.74 RAB9A (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL2086388 0.73 NPC1 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200062719-A1 Application of Imidazopyridine Derivatives in Regenerative Medicine UNIVERSITY OF HEIDELBERG (DE) 2020-02-27 US claimed
EP-3611256-A1 APPLICATION OF IMIDAZOPYRIDINE DERIVATIVES IN REGENERATIVE MEDICINE Universität Heidelberg (DE) 2020-02-19 EP claimed
US-20200062719-A1 Application of Imidazopyridine Derivatives in Regenerative Medicine UNIVERSITY OF HEIDELBERG (DE) 2020-02-27 US disclosed
US-20200062719-A1 Application of Imidazopyridine Derivatives in Regenerative Medicine UNIVERSITY OF HEIDELBERG (DE) 2020-02-27 US disclosed
EP-3611256-A1 APPLICATION OF IMIDAZOPYRIDINE DERIVATIVES IN REGENERATIVE MEDICINE Universität Heidelberg (DE) 2020-02-19 EP disclosed
EP-3611256-A1 APPLICATION OF IMIDAZOPYRIDINE DERIVATIVES IN REGENERATIVE MEDICINE Universität Heidelberg (DE) 2020-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062719-A1 Application of Imidazopyridine Derivatives in Regenerative Medicine DOT1L, NSD1, KDM3A NPC1 4209/4885RAB9A 3350/4885SMN1; SMN2 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.